Home > Insider Trading > Filing (0001127602-23-030566)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591312	I Bassil Dahiyat	C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-29	65,001	$11.05	357,929	No	4	M	Direct
Common Stock	Disposition	2023-12-29	45,000	$20.93	312,929	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-12-29	65,001	$0.00	65,001	$11.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-20	No	4	M	Direct

Footnotes

Underlying option due to expire in February 2024.
Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 304 shares acquired in June 2023 and 408 shares acquired in December 2023.
Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.